Pharmacological Modulation of Cognitivr Test Solution in Mice of Two Genotypes
- Authors: Perepelkina O.V.1, Poletaeva I.I.1
- 
							Affiliations: 
							- Lomonossov Moscow State University
 
- Issue: Vol 518, No 1 (2024)
- Pages: 93-95
- Section: Articles
- URL: https://rjpbr.com/2686-7389/article/view/651405
- DOI: https://doi.org/10.31857/S2686738924050169
- ID: 651405
Cite item
Abstract
Mice of two strains selected for successful solution of “object permanence” test and for lack of such solution demonstrated the differential reaction to injections of two drugs. The injections of atomoxetine. which blocks the noradrenaline reuptake, and of ‘non-benzodiazepine” anxiolytic afobazol was different. The success of solutions increased in mice selected for this test “non-solution”: and decreased or was inefficient in mice, selected for successful solution of object permanence cognitive test.
Keywords
Full Text
 
												
	                        About the authors
O. V. Perepelkina
Lomonossov Moscow State University
							Author for correspondence.
							Email: ingapoletaeva@mail.ru
				                					                																			                												                	Russian Federation, 							Moscow						
I. I. Poletaeva
Lomonossov Moscow State University
														Email: ingapoletaeva@mail.ru
				                					                																			                												                	Russian Federation, 							Moscow						
References
- Полетаева И.И., Перепелкина О.В., Зорина З.А. // Биофизика. 2023. Т. 68, № 5, С. 1046–1056.
- Galsworthy M.J., Paya-Cano J. L., Liu L., et al. // Behav. Genet. 2005. V. 35, № 5. P. 675-692
- Cuevas J., Rodriguez A., Behensky A., et al. // J Pharmacol Exp Ther 2011. V. 339. P. 161–172.
- Уянаев А.А., Фисенко В.П. Хитров Т.К. // Бюлл. эксп. Биол. мед. 2003. Т.136. №2. 162–164.
- Baria A., Xua S., Pignatelli M. et al. // PNAS. 2020. V. 117. №46. P. 29080–29089
- Ptukha M., Fesenko Z., Belskaya A., et al. // Biomolecules 2022, 12, 1484.
- Perepelkina O.V., Poletaeva I.I. // Neurol. Int. 2023. V. 15. № 2. P. 649-660;
- Chloe S. Chernoff C.S., Hynes T.J., et al. // Psychopharmac. 2024. V. 241. P.767–783.
- Ptukha M., Fesenko Z., Belskaya A., et al. // Biomolecules 2022, 12, 1484.
- Cain R.E., Wasserman M.C., Waterhouse B.D., McGaughy J.A. // Dev Cogn Neurosci. 2011. V. 1.№ 4. P. 552–559.
- Salomons A. R., Arndt S.S., Ohl F. // J. Behav. Brain Sci. 2013. №3. P. 210-216
- Калинина Т.С., Шимширт А.А., Волкова А.В., и др. // Эксп. клин. фармак. 2016. Т. 79. № 10. С. 3–7.
- Robinson E.D.J. // Psychopharm. 2012. V. 219. P. 303–312.
- Robbins T.W. // Br J Pharmacol. 2017. V. 174. № 19. P. 3191–3199
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
									

 
  
  
  Email this article
			Email this article 

 Open Access
		                                Open Access Access granted
						Access granted
